These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21311763)

  • 1. DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.
    Jaiswal AS; Banerjee S; Aneja R; Sarkar FH; Ostrov DA; Narayan S
    PLoS One; 2011 Feb; 6(2):e16691. PubMed ID: 21311763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel inhibitor of DNA polymerase beta enhances the ability of temozolomide to impair the growth of colon cancer cells.
    Jaiswal AS; Banerjee S; Panda H; Bulkin CD; Izumi T; Sarkar FH; Ostrov DA; Narayan S
    Mol Cancer Res; 2009 Dec; 7(12):1973-83. PubMed ID: 19996303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells.
    Jaiswal AS; Panda H; Law BK; Sharma J; Jani J; Hromas R; Narayan S
    PLoS One; 2015; 10(5):e0123808. PubMed ID: 25933036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid Asp181 of 5'-flap endonuclease 1 is a useful target for chemotherapeutic development.
    Panda H; Jaiswal AS; Corsino PE; Armas ML; Law BK; Narayan S
    Biochemistry; 2009 Oct; 48(42):9952-8. PubMed ID: 19769410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methoxyamine potentiates DNA single strand breaks and double strand breaks induced by temozolomide in colon cancer cells.
    Taverna P; Liu L; Hwang HS; Hanson AJ; Kinsella TJ; Gerson SL
    Mutat Res; 2001 May; 485(4):269-81. PubMed ID: 11585361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.
    Liu L; Taverna P; Whitacre CM; Chatterjee S; Gerson SL
    Clin Cancer Res; 1999 Oct; 5(10):2908-17. PubMed ID: 10537360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation.
    Stachelek GC; Dalal S; Donigan KA; Campisi Hegan D; Sweasy JB; Glazer PM
    Cancer Res; 2010 Jan; 70(1):409-17. PubMed ID: 20028873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells.
    Curtin NJ; Wang LZ; Yiakouvaki A; Kyle S; Arris CA; Canan-Koch S; Webber SE; Durkacz BW; Calvert HA; Hostomsky Z; Newell DR
    Clin Cancer Res; 2004 Feb; 10(3):881-9. PubMed ID: 14871963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death.
    Trivedi RN; Almeida KH; Fornsaglio JL; Schamus S; Sobol RW
    Cancer Res; 2005 Jul; 65(14):6394-400. PubMed ID: 16024643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis.
    Narayan S; Sharma R
    Life Sci; 2015 Oct; 139():145-52. PubMed ID: 26334567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Base excision repair as a therapeutic target in colon cancer.
    Liu L; Nakatsuru Y; Gerson SL
    Clin Cancer Res; 2002 Sep; 8(9):2985-91. PubMed ID: 12231545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human methyl purine DNA glycosylase and DNA polymerase beta expression collectively predict sensitivity to temozolomide.
    Trivedi RN; Wang XH; Jelezcova E; Goellner EM; Tang JB; Sobol RW
    Mol Pharmacol; 2008 Aug; 74(2):505-16. PubMed ID: 18477668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models.
    Holt SV; Logié A; Odedra R; Heier A; Heaton SP; Alferez D; Davies BR; Wilkinson RW; Smith PD
    Br J Cancer; 2012 Feb; 106(5):858-66. PubMed ID: 22343622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair.
    Higuchi F; Nagashima H; Ning J; Koerner MVA; Wakimoto H; Cahill DP
    Clin Cancer Res; 2020 Apr; 26(7):1690-1699. PubMed ID: 31900275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of temozolomide and hyperthermia on human melanoma cell growth and O6-methylguanine-DNA methyltransferase activity.
    Pagani E; Falcinelli S; Pepponi R; Turriziani M; Caporaso P; Caporali S; Bonmassar E; D'Atri S
    Int J Oncol; 2007 Feb; 30(2):443-51. PubMed ID: 17203227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure/function analysis of the interaction of adenomatous polyposis coli with DNA polymerase beta and its implications for base excision repair.
    Balusu R; Jaiswal AS; Armas ML; Kundu CN; Bloom LB; Narayan S
    Biochemistry; 2007 Dec; 46(49):13961-74. PubMed ID: 17999539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells.
    de Castro E Gloria H; Jesuíno Nogueira L; Bencke Grudzinski P; da Costa Ghignatti PV; Guecheva TN; Motta Leguisamo N; Saffi J
    BMC Cancer; 2021 Apr; 21(1):448. PubMed ID: 33888065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel polymerase β inhibitor from phage displayed peptide library augments the anti-tumour effects of temozolomide on colorectal cancer.
    Qin L; Huiwen M; Wang J; Wang Y; Khan SA; Zhang Y; Qiu H; Jiang L; He L; Zhang Y; Jia S
    J Chemother; 2022 Oct; 34(6):391-400. PubMed ID: 34870566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide: mechanisms of action, repair and resistance.
    Zhang J; Stevens MF; Bradshaw TD
    Curr Mol Pharmacol; 2012 Jan; 5(1):102-14. PubMed ID: 22122467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance.
    Yamauchi T; Ogawa M; Ueda T
    Mol Pharmacol; 2008 Jul; 74(1):82-91. PubMed ID: 18430789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.